Atlas Trials

Observational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD Not on Dialysis

Clinical trial NCT02185911 · COMPLETED

Trial details

NCT number
NCT02185911
Sponsor
Amgen
Status
COMPLETED
Study type
OBSERVATIONAL
AnaemiaChronic Kidney Disease (CKD)
Start date
2014-06-01
Primary completion
2015-04-01
Enrollment
308

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.